The U.S. is grappling with an enduring shortage of the pediatric antibiotic, Amoxicillin. This has left healthcare providers seeking alternatives for treating common childhood infections. Factors contributing to the shortage include surging demand, economic disincentives for manufacturers, and a need for improved drug supply monitoring.
full article